A. “Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling,” by Natura Myeku, Catherine L. Clelland, Sheina Emrani, Nikolay V. Kukushkin, Wai Haung Yu, Alfred L. Goldberg & Karen E. Duff (Vol. 22, No. 1, January 2016, p. 46-53).
www.nature.com/nm/journal/v22/n1/abs/nm.4011.html
B. “Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes,” by Wenzhang Wang, Xinglong Wang, Hisashi Fujioka, Charles Hoppel, Alan L Whone, Maeve A. Caldwell, Peter J. Cullen, Jun Liu & Xiongwei Zhu (Vol. 22, No. 1, January 2016, p. 54-63).
